Depressive symptoms and social context modulate oxytocin's effect on negative memory recall

• Main Authors: Brown, C.A (Author), Cardoso, C. (Author), Ellenbogen, M.A (Author), Orlando, M.A (Author), Wong, S.F (Author)
• Format: Article
• Language: English
• Published: NLM (Medline) 2021
• Subjects: Administration, Intranasal; autobiographical memory; depression; Depression; double blind procedure; Double-Blind Method; episodic memory; human; Humans; intranasal drug administration; intranasal oxytocin; Memory, Episodic; oxytocin; Oxytocin; social behavior; Social Behavior; social context; social environment; Social Environment
• Online Access: View Fulltext in Publisher

 Oxytocin promotes social affiliation across various species, in part by altering social cognition to facilitate approach behaviour. However, the effects of intranasal oxytocin on human social cognition are mixed, perhaps because its effects are context dependent and subject to inter-individual differences. Few studies have included explicit manipulations of social context to test this supposition. We examined oxytocin's effects on autobiographical memory recall in two contexts, with and without social contact, and evaluated whether these effects were moderated by depressive symptoms. Two non-clinical samples (Study 1, n = 48; Study 2, n = 63) completed randomised, placebo-controlled, within-subject experiments. We assessed autobiographical memory recall across two sessions (intranasal oxytocin or placebo) and two contexts (memories elicited by an experimenter or by computer). Overall, intranasal oxytocin increased ratings of the vividness of recalled memories during the social context only. Individuals with elevated depressive symptoms also recalled memories that were more negative following oxytocin relative to placebo only in the non-social context across the two studies. Findings highlight the negative consequences of increasing oxytocin bioavailability in vulnerable persons in the absence of social contact. Contextual factors such as social isolation among depressed populations may complicate the clinical use of oxytocin. © The Author(s) 2021. Published by Oxford University Press.